Cheerwine expands footprint in the South
SALISBURY, N.C. — Cheerwine, a soft drink brand, on Tuesday announced that it would be expanding to markets in Alabama, western Georgia and the Florida Panhandle via distribution with Buffalo Rock Co., a Pepsi bottler.
The partnership will bring Cheerwine to more than 6.5 million new customers and will be made in Buffalo Rock’s production facility in Birmingham, Ala. It’s a move toward the company’s goal of being available in all 50 states by 2017, the company said.
"We strongly believe this new relationship has all the ingredients to be a match made in heaven: one of the nation’s leading independent bottlers joining forces with one of America’s most beloved independent soft drink brands, all taking shape in the South,” said Tom Barbitta, SVP marketing and sales for Cheerwine. “This partnership gives our brand a foothold in a part of the country where there is solid demand for Cheerwine.
Buffalo Rock is expected to offer the beverage in a variety of packaging, which includes 12-pack cans, 20-oz. and two-liter PET bottles and 12-oz. glass bottles.
McNeil launches ‘Stories of Strength’ program in partnership with Target
FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Monday announced the launch of Stories of Strength, a program that encourages people to honor someone who has been a source of strength in their lives. Each story shared will trigger a $1 donation — with a minimum donation of $50,000 and maximum donation of $75,000 — from Extra Strength Tylenol to DoSomething.org, an organization that activates young people to be strong leaders for social change.
For Stories of Strength, Extra Strength Tylenol is partnering with actress Andie McDowell and her daughter, actress and singer Rainey Qualley, who have an inspirational story of how strength has been passed down in their family from generation to generation.
"As a single mother of four, my mother taught me that you always want to show up strong for the moments that really matter with family, friends and community," McDowell said. "I now recognize how her strength helped shape the person I am today and the mother that I have become. I¹m proud to partner with Tylenol on Stories of Strength to give everyone a chance to honor the person who has helped make them strong for what¹s most important in life."
Through Stories of Strength, Andie also had the opportunity to learn how her strength has inspired her daughter.
"Throughout my life, my mom has been an example of fearless strength, teaching me to always show up strong and treat each opportunity in life as a real privilege," Qualley said. "It¹s an honor to celebrate the strength of my mom while inspiring others to share their stories to support a great cause in DoSomething.org."
To get involved, participants can visit TylenolStoriesofStrength.com and share their personal story via video or photo and an accompanying message. Each story shared will trigger a $1 donation to DoSomething.org, a nonprofit organization that spearheads national philanthropic campaigns through grants for projects, so people can take action on causes they are passionate about.
Participants also will have a chance to win a Target GiftCard.
"We hope that sharing these stories will motivate people to keep inspiring others to be strong," stated Katie Devine, VP marketing at McNeil Consumer Healthcare. "We love seeing how Andie and Rainey draw strength from each other. For generations, Tylenol has been hearing amazing stories from consumers about how they feel once their pain is relieved, and how feeling strong has helped them stay connected with those they love. We are excited to now share those stories and, through our partnership with DoSomething.org, motivate young people to take action to be strong leaders for social change."
Target Corporation is a retailer partner for the Stories of Strength program.
Study: Almost half of all narcotic prescriptions written by 5% of opioid prescribers
SAN DIEGO — As many as 40% of U.S. narcotic prescriptions in 2011-2012 were written by only 5% of opioid prescribers, according to a study Express Scripts presented Monday at AcademyHealth’s annual research meeting.
The study identifies prescribers who prescribe opioids at a much higher rate than peers who are in the same specialty, treat patients of similar age and practice in the same geographic region. Express Scripts’ multivariate approach to identifying high prescribers is the first of its kind, the company noted.
According to the analysis, high prescribers wrote an average of 3.5 times more opioid prescriptions — 4.6 prescriptions per patient compared to 1.3 in their peer group. Opioid cost per patient per day of therapy was nearly five times higher, on average, for patients treated by high prescribers.
Internal medicine and family practice are among the specialties with the highest prevalence of high prescribers, even after accounting for the volume of prescribers in these two specialties. Nearly 20% of the high prescribers were only prescribing opioids to one patient.
"While narcotics provide needed pain relief to many patients, high prescribing patterns are a potential area of concern," stated Glen Stettin, SVP clinical, research and new solutions at Express Scripts. "The findings of this study could indicate the need for better education about prescribing guidelines or tighter controls on narcotic prescribing."
This research, when applied to prescriber databases, can help identify potential issues with the prescription of narcotics and can be incorporated into efforts to help plan sponsors fight prescription drug fraud and abuse, Express Scripts noted.
This research also highlights the value of clinical specialization. Of the more than half million prescribers analyzed for this study, only 385 were identified as pain specialists.
"The rise in opioid abuse-related deaths has coincided with increased prescribing of narcotics," Stettin said."Because nearly all of these prescribers specialize in an area other than pain management, the specialist pharmacists within our neuroscience Therapeutic Resource Center can help assure appropriate use of these potent medications and close critical gaps in care."